CoChat

Mining the Human Tissue Proteome for Protein Citrullination

Open access
Lee, Chien-Yun, Wang, Dongxue, Wilhelm, Mathias, Zolg, Daniel P., Schmidt, Tobias, Schnatbaum, Karsten, Reimer, Ulf, Pontén, Fredrik, Uhlén, Mathias, Hahne, Hannes, Kuster, Bernhard · 2018 · Molecular & Cellular Proteomics
Cited by 122

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Citrullination is a posttranslational modification of arginine catalyzed by five peptidylarginine deiminases (PADs) in humans. The loss of a positive charge may cause structural or functional alterations, and while the modification has been linked to several diseases, including rheumatoid arthritis (RA) and cancer, its physiological or pathophysiological roles remain largely unclear. In part, this is owing to limitations in available methodology to robustly enrich, detect, and localize the modification. As a result, only a few citrullination sites have been identified on human proteins with high confidence. In this study, we mined data from mass-spectrometry-based deep proteomic profiling of 30 human tissues to identify citrullination sites on endogenous proteins. Database searching of ∼70 million tandem mass spectra yielded ∼13,000 candidate spectra, which were further triaged by spectrum quality metrics and the detection of the specific neutral loss of isocyanic acid from citrullinated peptides to reduce false positives. Because citrullination is easily confused with deamidation, we synthetized ∼2,200 citrullinated and 1,300 deamidated peptides to build a library of reference spectra. This led to the validation of 375 citrullination sites on 209 human proteins. Further analysis showed that >80% of the identified modifications sites were new, and for 56% of the proteins, citrullination was detected for the first time. Sequence motif analysis revealed a strong preference for Asp and Gly, residues around the citrullination site. Interestingly, while the modification was detected in 26 human tissues with the highest levels found in the brain and lung, citrullination levels did not correlate well with protein expression of the PAD enzymes. Even though the current work represents the largest survey of protein citrullination to date, the modification was mostly detected on high abundant proteins, arguing that the development of specific enrichment methods would be required in order to study the full extent of cellular protein citrullination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.ra118.000696

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 53

  1. Hirofumi, 2011, Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms, Adv. Biosci. Biotechnol, 2, 7
  2. Nakashima, 1999, Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3), J. Biol. Chem, 274, 27786, 10.1074/jbc.274.39.27786 · DOI · Paper page
  3. Kanno, 2000, Human peptidylarginine deiminase type III: Molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin, J. Invest. Dermatol, 115, 813, 10.1046/j.1523-1747.2000.00131.x · DOI
  4. Ishigami, 2002, Human peptidylarginine deiminase type II: Molecular cloning, gene organization, and expression in human skin, Arch. Biochem. Biophys, 407, 25, 10.1016/S0003-9861(02)00516-7 · DOI
  5. Guerrin, 2003, cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I, Biochem. J, 370, 167, 10.1042/bj20020870 · DOI
  6. Zhang, 2004, cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type VI, Acta Biochim. Polonica, 51, 1051, 10.18388/abp.2004_3538 · DOI
  7. György, 2006, Citrullination: A posttranslational modification in health and disease, Int. J. Biochem. Cell Biol, 38, 1662, 10.1016/j.biocel.2006.03.008 · DOI · Paper page
  8. Witalison, 2015, Protein arginine deiminases and associated citrullination: Physiological functions and diseases associated with dysregulation, Curr. Drug Targets, 16, 700, 10.2174/1389450116666150202160954 · DOI · Paper page
  9. Schellekens, 1998, Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies, J. Clin. Invest, 101, 273, 10.1172/JCI1316 · DOI · Paper page
  10. Wegner, 2010, Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis, Immunol. Rev, 233, 34, 10.1111/j.0105-2896.2009.00850.x · DOI · Paper page
  11. Pruijn, 2010, The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis, Arthritis Res. Therapy, 12, 203, 10.1186/ar2903 · DOI
  12. Puszczewicz, 2011, Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis, Arch. Med. Sci, 7, 189, 10.5114/aoms.2011.22067 · doi:10.5114/aoms.2011.22067
  13. Fuhrmann, 2016, Protein arginine methylation and citrullination in epigenetic regulation, ACS Chem. Biol, 11, 654, 10.1021/acschembio.5b00942 · DOI
  14. Lee, 2005, Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination, Proc. Natl. Acad. Sci. U.S.A, 102, 3611, 10.1073/pnas.0407159102 · DOI · Paper page
  15. Snijders, 2015, Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA, RNA, 21, 347, 10.1261/rna.045138.114 · DOI
  16. De Ceuleneer, 2012, In vivo relevance of citrullinated proteins and the challenges in their detection, Proteomics, 12, 752, 10.1002/pmic.201100478 · DOI
  17. Hensen, 2014, Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination, Mol. Cell Proteomics, 13, 388, 10.1074/mcp.R113.033746 · DOI
  18. Liu, 2017, Probing the roles of calcium-binding sites during the folding of human peptidylarginine deiminase 4, Scientific Rep, 7, 2429, 10.1038/s41598-017-02677-1 · doi:10.1038/s41598-017-02677-1
  19. Knuckley, 2010, Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3, Biochemistry, 49, 4852, 10.1021/bi100363t · DOI · Paper page
  20. Tutturen, 2010, A technique for the specific enrichment of citrulline-containing peptides, Anal. Biochem, 403, 43, 10.1016/j.ab.2010.04.012 · doi:10.1016/j.ab.2010.04.012
  21. Tutturen, 2013, Specific biotinylation and sensitive enrichment of citrullinated peptides, Anal. Bioanal. Chem, 405, 9321, 10.1007/s00216-013-7376-1 · DOI
  22. Tutturen, 2014, Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides, J. Proteome Res, 13, 2867, 10.1021/pr500030x · DOI
  23. Lewallen, 2015, Chemical proteomic platform to identify citrullinated proteins, ACS Chem. Biol, 10, 2520, 10.1021/acschembio.5b00438 · DOI · Paper page
  24. Jin, 2013, Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation, Proteomics, 13, 2682, 10.1002/pmic.201300064 · DOI · Paper page
  25. Ruprecht, 2017, Hydrophilic strong anion exchange (hSAX) chromatography enables deep fractionation of tissue proteomes, Methods Mol. Biol, 1550, 69, 10.1007/978-1-4939-6747-6_7 · DOI
  26. Nesvizhskii, 2003, A statistical model for identifying proteins by tandem mass spectrometry, Anal. Chem, 75, 4646, 10.1021/ac0341261 · DOI · Paper page
  27. Zolg, 2017, Building proteome tools based on a complete synthetic human proteome, Nat. Methods, 14, 259, 10.1038/nmeth.4153 · DOI · Paper page
  28. Wan, 2002, Comparing similar spectra: From similarity index to spectral contrast angle, J. Am. Soc. Mass Spectr, 13, 85, 10.1016/S1044-0305(01)00327-0 · DOI · Paper page
  29. Cox, 2011, Andromeda: A peptide search engine integrated into the MaxQuant environment, J. Proteome Res, 10, 1794, 10.1021/pr101065j · DOI · Paper page
  30. Tyanova, 2016, The MaxQuant computational platform for mass spectrometry-based shotgun proteomics, Nat. Protocols, 11, 2301, 10.1038/nprot.2016.136 · DOI · Paper page
  31. O'Shea, 2013, pLogo: A probabilistic approach to visualizing sequence motifs, Nat. Methods, 10, 1211, 10.1038/nmeth.2646 · DOI · Paper page
  32. Vizcaíno, 2016, 2016 update of the PRIDE database and its related tools, Nucleic Acids Res, 44, 11033, 10.1093/nar/gkw880 · DOI · Paper page
  33. Sanborn, 1968, The interaction of trypsin with neutral substrates and modifiers, Biochemistry, 7, 3616, 10.1021/bi00850a039 · doi:10.1021/bi00850a039
  34. Bennike, 2013, Optimizing the identification of citrullinated peptides by mass spectrometry: Utilizing the inability of trypsin to cleave after citrullinated amino acids, J. Proteomics Bioinform, 6, 288, 10.4172/jpb.1000293 · DOI
  35. Falick, 1993, Low-mass ions produced from peptides by high-energy collision-induced dissociation in tandem mass spectrometry, J. Am. Soc. Mass Spectr, 4, 882, 10.1016/1044-0305(93)87006-X · doi:10.1016/1044-0305(93)87006-x
  36. Zee-Yong Park, 2007, Assigning in vivo carbamylation and acetylation in human lens proteins using tandem mass spectrometry and database searching, Int. J. Mass Spectr, 259, 13
  37. Pritzker, 1999, The developmental expression and activity of peptidylarginine deiminase in the mouse, Neurosci. Lett, 266, 161, 10.1016/S0304-3940(99)00276-1 · doi:10.1016/s0304-3940(99)00276-1
  38. Nicholas, 2003, Immunohistochemical localization of citrullinated proteins in adult rat brain, J. Comparat. Neurol, 459, 251, 10.1002/cne.10607 · doi:10.1002/cne.10607
  39. Acharya, 2012, Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease, J. Autoimmun, 38, 369, 10.1016/j.jaut.2012.03.004 · DOI
  40. Moscarello, 2007, The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis, Neurochem. Res, 32, 251, 10.1007/s11064-006-9144-5 · DOI · Paper page
  41. Bawadekar, 2016, Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation, Arthritis Res. Ther, 18, 173, 10.1186/s13075-016-1068-0 · DOI
  42. Moldoveanu, 2009, Inflammatory mechanisms in the lung, J. Inflamm. Res, 2, 1
  43. Makrygiannakis, 2006, Citrullination is an inflammation-dependent process, Ann. Rheumat. Diseases, 65, 1219, 10.1136/ard.2005.049403 · DOI · Paper page
  44. Redman, 2004, Preeclampsia and the systemic inflammatory response, Sem. Nephrol, 24, 565, 10.1016/j.semnephrol.2004.07.005 · doi:10.1016/j.semnephrol.2004.07.005
  45. Nachat, 2005, Peptidylarginine deiminase isoforms 1–3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin, J. Invest. Dermatol, 124, 384, 10.1111/j.0022-202X.2004.23568.x · DOI
  46. Asaga, 2001, Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils, J. Leukocyte Biol, 70, 46, 10.1189/jlb.70.1.46 · DOI · Paper page
  47. Mohanan, 2013, Identification of macrophage extracellular trap-like structures in mammary gland adipose tissue: A preliminary study, Frontiers Immunol, 4, 67, 10.3389/fimmu.2013.00067 · DOI
  48. van Beers, 2013, Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice, Biochimie (Paris), 95, 299, 10.1016/j.biochi.2012.09.029 · DOI
  49. Assohou-Luty, 2014, The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities, Biochim. Biophys. Acta, 1844, 829, 10.1016/j.bbapap.2014.02.019 · DOI
  50. Olson, 2017, An in silico analysis of primary and secondary structure specificity determinants for human peptidylarginine deiminase types 2 and 4, Computat. Biol. Chem, 70, 107, 10.1016/j.compbiolchem.2017.08.001 · doi:10.1016/j.compbiolchem.2017.08.001
  51. Heinrich, 2009, Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA, J. Biol. Chem, 284, 14303, 10.1074/jbc.M901026200 · DOI
  52. Kanhoush, 2010, Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts, Nucleus, 1, 109, 10.4161/nucl.1.1.10857 · DOI
  53. Jobert, 2009, PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function, Experimental Cell Res, 315, 1273, 10.1016/j.yexcr.2008.12.008 · DOI

Cited by

See all 122

Metadata

Authors
Lee, C.-Y., Wang, D., Wilhelm, M., Zolg, D. P., Schmidt, T., Schnatbaum, K., Reimer, U., Pontén, F., Uhlén, M., Hahne, H., & Kuster, B.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2018-07
Volume
17
Issue
7
Pages
1378-1391
ISSN
1535-9476 (ISSN-L)
OpenAlex
W2796138116
Cited by
122
References
3
FWCI
5.35
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
Deutscher Akademischer Austauschdienst (DAAD) (DAAD/MoSt Sandwich-Program grant no 57261473)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mining the Human Tissue Proteome for Protein Citrullination. https://app.cochat.ai/papers/10.1074/mcp.ra118.000696
The paper
Lee, C.-Y., Wang, D., Wilhelm, M., Zolg, D. P., Schmidt, T., Schnatbaum, K., Reimer, U., Pontén, F., Uhlén, M., Hahne, H., & Kuster, B. (2018). Mining the Human Tissue Proteome for Protein Citrullination. Molecular & Cellular Proteomics. https://doi.org/10.1074/mcp.ra118.000696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.